MedPath

Evaluation of Effect of Probiotics on Nonalcoholic Fatty Liver Disease

Not Applicable
Conditions
non alcoholic fatty liver disease.
nonalcoholic steatohepatitis
Registration Number
IRCT2013100414882N1
Lead Sponsor
Isfahan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
64
Inclusion Criteria

children and adolescents with fatty liver disease; 10-18 years; BMI=> 85%
Exclusion criteria: alcohol ingestion; other baseline liver disease; ingestion of medication

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
iver aminotransferase level. Timepoint: before and 12 weeks after intervention. Method of measurement: biochemical laboratory testes.;Grade of fatty liver. Timepoint: before and 12 weeks after intervention. Method of measurement: sonography.
Secondary Outcome Measures
NameTimeMethod
ipid profiles. Timepoint: before and 12 weeks after intervention. Method of measurement: biochemical laboratory testes.
© Copyright 2025. All Rights Reserved by MedPath